Sign in

CIK 0001736730

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Camp4 Therapeutics Corp

Sign in to watch
Ticker
CAMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-651-8867
Business address
100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$39,600
in 1 filing
Open-market sales, last 90 days
$2,280,864
in 3 filings

Net −$2,241,264. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Schwab Andrew J. −$2.3M Director sold 21% of stake
  2. Gold Kelly +$40K Chief Financial Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-08-31 Gold Kelly Chief Financial Officer Purchase +10,000 $3.96 $40K 10,000
2026-08-03 Gold Kelly Chief Financial Officer Purchase +6,551 $1.65 $11K 74,428
2026-04-01 Gold Kelly Chief Financial Officer Grant or award · Stock Option (Right to Buy) +215,000 215,000
2025-12-11 Gold Kelly Chief Financial Officer Grant or award · Stock Option (Right to Buy) +190,000 190,000
2025-09-11 Gold Kelly Chief Financial Officer Purchase +6,060 $1.65 $10K 67,877
2025-04-01 Gold Kelly Chief Financial Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000

Page 1 of 1 · 6 trades